Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
58.60
-0.65 (-1.10%)
Jun 26, 2026, 5:35 PM CET
BME:ROVI Market Cap
BME:ROVI has a market cap or net worth of €3 billion as of June 26, 2026. Its market cap has increased by 6.45% in one year.
Market Cap
3.00B
Enterprise Value
3.03B
Revenue
741.09M
Ranking
n/a
PE Ratio
22.74
Stock Price
€58.60
Market Cap Chart
Since December 18, 2007, BME:ROVI's market cap has increased from 356.09K to 3.00B, an increase of 841,642.42%. That is a compound annual growth rate of 62.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 3.00B | -7.72% |
| Dec 31, 2025 | 3.25B | 0.87% |
| Dec 31, 2024 | 3.22B | 0.22% |
| Dec 29, 2023 | 3.21B | 66.93% |
| Dec 30, 2022 | 1.92B | -53.49% |
| Dec 30, 2021 | 4.14B | 97.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.43B |
| Almirall | 2.42B |
| Faes Farma | 1.43B |
| Pharma Mar | 1.25B |
| Clínica Baviera | 906.65M |
| Oryzon Genomics | 246.65M |
| Laboratorio Reig Jofre | 220.63M |
| Prim, S.A. | 218.63M |